| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate. the Flight Trial
|
Bradbury, Charlotte A
|
|
|
136 |
S2 |
p. LBA-2
|
artikel
|
| 2 |
Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms
|
Williams, Nicholas
|
|
|
136 |
S2 |
p. LBA-1
|
artikel
|
| 3 |
Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs
|
Hochhaus, Andreas
|
|
|
136 |
S2 |
p. LBA-4
|
artikel
|
| 4 |
Enhancer Hijacking of BCL11B Defines a Subtype of Lineage Ambiguous Acute Leukemia
|
Montefiori, Lindsey
|
|
|
136 |
S2 |
p. LBA-3
|
artikel
|
| 5 |
ETNK1 Mutations in Atypical Chronic Myeloid Leukemia Induce a Mutator Phenotype That Can be Reverted with Phosphoethanolamine
|
Fontana, Diletta
|
|
|
136 |
S2 |
p. LBA-5
|
artikel
|
| 6 |
First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies
|
Pipe, Steven W.
|
|
|
136 |
S2 |
p. LBA-6
|
artikel
|
Tijdschrift beschrijving